Last reviewed · How we verify
E-SYNC T Cells
At a glance
| Generic name | E-SYNC T Cells |
|---|---|
| Also known as | Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13R alpha2 CAR T Cells, Autologous Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13R alpha2 CAR T Cells, Autologous Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ra2 CAR T Cells |
| Sponsor | Hideho Okada, MD, PhD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- E-SYNC T Cells CI brief — competitive landscape report
- E-SYNC T Cells updates RSS · CI watch RSS
- Hideho Okada, MD, PhD portfolio CI